Literature DB >> 22445934

Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery.

S P Patel1, P G Sullivan, T S Lyttle, D S K Magnuson, A G Rabchevsky.   

Abstract

We have recently documented that treatment with the alternative biofuel, acetyl-L-carnitine (ALC, 300 mg/kg), as late as 1 h after T10 contusion spinal cord injury (SCI), significantly maintained mitochondrial function 24 h after injury. Here we report that after more severe contusion SCI centered on the L1/L2 segments that are postulated to contain lamina X neurons critical for locomotion (the "central pattern generator"), ALC treatment resulted in significant improvements in acute mitochondrial bioenergetics and long-term hind limb function. Although control-injured rats were only able to achieve slight movements of hind limb joints, ALC-treated animals produced consistent weight-supported plantar steps 1 month after injury. Such landmark behavioral improvements were significantly correlated with increased tissue sparing of both gray and white matter proximal to the injury, as well as preservation of choline acetyltransferase (ChAT)-positive neurons in lamina X rostral to the injury site. These findings signify that functional improvements with ALC treatment are mediated, in part, by preserved locomotor circuitry rostral to upper lumbar contusion SCI. Based on beneficial effects of ALC on mitochondrial bioenergetics after injury, our collective evidence demonstrate that preventing mitochondrial dysfunction acutely "promotes" neuroprotection that may be associated with the milestone recovery of plantar, weight-supported stepping.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22445934      PMCID: PMC3358433          DOI: 10.1016/j.neuroscience.2012.03.006

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  106 in total

1.  Evaluation of the effect of acetyl L-carnitine on experimental cisplatin nephrotoxicity.

Authors:  Ozlem Tufekci; Dilek Gunes; Candan Ozoğul; Efsun Kolatan; Zekiye Altun; Osman Yilmaz; Safiye Aktaş; Zübeyde Erbayraktar; Günay Kirkim; Kamer Mutafoğlu; Alper Soylu; Bülent Serbetçioğlu; Enis Alpin Güneri; Nur Olgun
Journal:  Chemotherapy       Date:  2009-12-08       Impact factor: 2.544

2.  Tempol protection of spinal cord mitochondria from peroxynitrite-induced oxidative damage.

Authors:  Yiqin Xiong; Indrapal N Singh; Edward D Hall
Journal:  Free Radic Res       Date:  2009-06

3.  Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor.

Authors:  Lorenzo Di Cesare Mannelli; Carla Ghelardini; Menotti Calvani; Raffaella Nicolai; Luigi Mosconi; Annarita Toscano; Alessandra Pacini; Alessandro Bartolini
Journal:  J Neurosci Res       Date:  2009-01       Impact factor: 4.164

4.  Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury.

Authors:  Samir P Patel; Patrick G Sullivan; Jignesh D Pandya; Alexander G Rabchevsky
Journal:  J Neurosci Res       Date:  2009-01       Impact factor: 4.164

5.  Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study.

Authors:  M B Bracken; M J Shepard; K G Hellenbrand; W F Collins; L S Leo; D F Freeman; F C Wagner; E S Flamm; H M Eisenberg; J H Goodman
Journal:  J Neurosurg       Date:  1985-11       Impact factor: 5.115

6.  Acetyl-L-carnitine ameliorates caerulein-induced acute pancreatitis in rats.

Authors:  Hossam M M Arafa; Ramadan A M Hemeida; Mohamed I A Hassan; Mohammed H Abdel-Wahab; Osama A Badary; Farid M A Hamada
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-04-03       Impact factor: 4.080

7.  Plasticity of lumbosacral propriospinal neurons is associated with the development of autonomic dysreflexia after thoracic spinal cord transection.

Authors:  Shaoping Hou; Hanad Duale; Adrian A Cameron; Sarah M Abshire; Travis S Lyttle; Alexander G Rabchevsky
Journal:  J Comp Neurol       Date:  2008-08-01       Impact factor: 3.215

8.  Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury.

Authors:  Wen Ru Yu; Tianyi Liu; Tara K Fehlings; Michael G Fehlings
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

Review 9.  Acylcarnitines: role in brain.

Authors:  Lauren L Jones; David A McDonald; Peggy R Borum
Journal:  Prog Lipid Res       Date:  2009-08-29       Impact factor: 16.195

10.  Evaluation of lenticular antioxidant and redox system components in the lenses of acetyl-L-carnitine treatment in BSO-induced glutathione deprivation.

Authors:  R Elanchezhian; M Sakthivel; M Isai; P Geraldine; P A Thomas
Journal:  Mol Vis       Date:  2009-07-31       Impact factor: 2.367

View more
  29 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

2.  Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo.

Authors:  Sheri L Peterson; Hal X Nguyen; Oscar A Mendez; Aileen J Anderson
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

3.  Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery.

Authors:  Samir P Patel; David H Cox; Jenna L Gollihue; William M Bailey; Werner J Geldenhuys; John C Gensel; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  Exp Neurol       Date:  2017-03-30       Impact factor: 5.330

Review 4.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

5.  Effects of Mitochondrial Transplantation on Bioenergetics, Cellular Incorporation, and Functional Recovery after Spinal Cord Injury.

Authors:  Jenna L Gollihue; Samir P Patel; Khalid C Eldahan; David H Cox; Renee R Donahue; Bradley K Taylor; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  J Neurotrauma       Date:  2018-04-30       Impact factor: 5.269

6.  Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels.

Authors:  Melissa D Laird; Pascaline Clerc; Brian M Polster; Gary Fiskum
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 7.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

8.  N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma.

Authors:  Samir P Patel; Patrick G Sullivan; Jignesh D Pandya; Glenn A Goldstein; Jenna L VanRooyen; Heather M Yonutas; Khalid C Eldahan; Johnny Morehouse; David S K Magnuson; Alexander G Rabchevsky
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

9.  Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy.

Authors:  Tyler G Demarest; Rosemary A Schuh; Jaylyn Waddell; Mary C McKenna; Gary Fiskum
Journal:  J Neurochem       Date:  2016-05-06       Impact factor: 5.372

10.  Serial Diffusion Tensor Imaging In Vivo Predicts Long-Term Functional Recovery and Histopathology in Rats following Different Severities of Spinal Cord Injury.

Authors:  Samir P Patel; Taylor D Smith; Jenna L VanRooyen; David Powell; David H Cox; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  J Neurotrauma       Date:  2016-02-11       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.